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Abstract 
Introduction: Thrombocytopenia is a common hematologic disorder observed in 
many pathological conditions in critically ill patients. The current study aimed at 
investigating the prevalence of thrombocytopenia and its relationship with the length 
of stay and mortality among intensive care unit (ICU) patients.  
Methods: The current prospective cohort study enrolled 150 patients consecutively 
admitted to the medical ICU during a nine-month period. Patients’ baseline 
characteristics and underlying diseases were recorded. Laboratory findings and 
admission mean platelets and platelet counts on the 3rd day of admission were 
obtained. Patients were divided into thrombocytopenic (platelet count of less than 
150×109/L or decrease of platelet to more than 50%) and non-thrombocytopenic 
groups according to the 3rd day platelet count.  
Results: Thrombocytopenia was detected in 53(35%) patients while 13 patients 
(8.6%) had severe thrombocytopenia (platelets count < 50 × 109/L). ICU stay and 
mortality were significantly higher in patients with thrombocytopenia compared with 
non-thrombocytopenic patients (16 ± 2.7 vs 12 ± 2.4 days, P = 0.01) and (45.5% vs 
37.3%, P = 00.1) respectively. 
Conclusions: Platelet might be considered as a prognosis monitor in ICU settings. 
Severe thrombocytopenia could be mentioned as a poor prognostic factor for 





© 2018. International Journal of 
Cardiovascular Practice. 
INTRODUCTION
Thrombocytopenia is a frequent abnormality in 
intensive care unit (ICU) patients that varies from 13% 
to 44% [1]. Thrombocytopenia is often multi-factorial 
and it is not easy to determine the exact cause of 
thrombocytopenia in ICU. It may cause higher 
mortality in critically ill patients [2]. Thrombocytopenia 
is defined as platelet count less than 150×109.L-1, but for 
ICU patients the amount is less than 100×109.L-1, and 
platelet counts less than 50×109.L-1 is known as severe 
thrombocytopenia [3, 4]. In addition to platelet count, 
mean platelet volume (MPV) is one of the factors that 
indicate platelet function [5]. Higher MPV values are 
associated with increased platelet activation. Platelet 
count and MPV are simple methods to monitor patient’s 
condition [6-10]. Thrombocytopenia may increase the 
risk of bleeding as well as thrombosis caused by platelets 
activation, according to the underlying mechanism [11, 
12]. 
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Thrombocytopenia in intensive care unit may cause 
bleeding, organ failure, and increase the length of 
hospitalization [3, 13, 14]. 
Etiologies of thrombocytopenia in critically ill patients 
are widely studied. Mechanisms that can result in 
thrombocytopenia in critically ill patients are 
hemodilution (decreased concentration of cells 
and solids in the blood resulting from gain of 
fluid), more platelet consumption (due to massive 
tissue trauma), bleeding, platelet sequestration, 
decreased platelet production, sepsis, and DIC 
(disseminated intravascular coagulation)  [15-17]. 
It is necessary to make the etiologic diagnosis to 
accommodate the patients benefit from appropriate 
treatment. Association between thrombocytopenia and 
prognosis of patients admitted in ICU was declared 
recently. The current study aimed at investigating the 
prevalence of thrombocytopenia and its relationship 
with the length of stay in ICU and mortality among ICU 
patients.  
METHODS 
The current histological cohort study enrolled 150 
patients above 18 years old consecutively admitted to 
ICU for more than two days (83 male and 67 female). 
This study protocol was approved by the Ethics 
Committee of Shahid Beheshti University of Medical 
Sciences. Patients had normal platelet range (more than 
150×109.L-1) in the beginning, and were followed until 
they were discharged or died. 
Patients’ baseline and demographic characteristics such 
as age, gender, and body mass index (BMI) were 
evaluated.  
Thrombocytopenia was defined as more than 50% 
decrease in platelet count or platelet count less than 
150×109.L-1 on the 3rd day. Patients were divided to 
thrombocytopenic and non-thrombocytopenic groups. 
Statistical Analysis 
Data were presented as means ± SD and qualitative 
variables as frequency (percentage). Statistical analyses 
were performed with SPSS software for Windows 
(Statistical Product and Service Solutions, version 20.0, 
SSPS Inc., Chicago, IL, USA). Student t test for 
quantitative variables and chi-squared test for 
quantitative variables were used. P values less than 0.05 
were considered as statistically significant. 
RESULTS 
Mean age of patients was 58.8 ± 11.9 years (range 46–
73). Patients’ characteristics are shown in Table 1. 
From 150 patients (83 male and 67 female) 
thrombocytopenia was detected in 53(35%) patients 
while 13 (8.6%) patients had severe thrombocytopenia 
(platelet count <50 × 109/L). Thrombocytopenia on 
the 3rd day of admission was detected in 40.2% and 
31.3% of females and males, respectively, which was not 
statistically different (P = 0.1). As shown in Table 2, 
admission mean platelets were similar in patients with 
thrombocytopenia and non-thrombocytopenic patients 
(243674x106 ± 7648 × 106/L and 26154 × 106 ± 8031 × 
106/L, respectively; P = 0.6), while the platelet counts 
on days 3-5 after admission significantly decreased in 
patients with thrombocytopenia (243674 × 106 ±7648 × 
106/L and 26154 × 106 ± 8031 × 106/L, respectively; P 
= 0.6). Overall duration of hospitalization was 
13.41±2.6 days, which was significantly higher in 
patients with thrombocytopenia compared with non-
thrombocytopenic patients (16 ± 2.7 vs 12 ± 2.4 days, 
respectively P = 0.01). 
 
Table 1: Patients baseline characteristics 
 Thrombocytopenic 
(n = 150) 
Age (years) 58.74  ±  11.93 
Gender (male) 83(55.3%) 
BMI  (Kg/m2) 34.63  ±  6.72 
Creatinine (mg/dl) 1.23  ±  0.68 
Platelet on admission (×109/L) 259364 ± 7438 
Admission cause  
Respiratory failure 63 (42%) 
Septic shock 34 (22.7%) 
Renal failure / ESRD 53 (35.3%) 
Systolic blood pressure (mmHg) 137.2 ± 11.1 
Heart rate (bpm) 73.6 ± 6.7 
Hospitalization duration (days) 13.6± 2.5 
Mortality (%) 60 (40%) 
Data in are presented as No. (%) or Mean ± SD. 
ESRD: end stage renal disease; bpm: beat per min 
 
The current study results demonstrated significant 
difference in ICU mortality between thrombocytopenic 
and non-thrombocytopenic patients (45.5% vs 37.3%, P 
= 0.01). The current study investigated the effect of 
sever thrombocytopenia (platelet count <50 × 109/L) 
on ICU mortality. As shown in Table 3, sever 
thrombocytopenia was associated with increased 
mortality compared with thrombocytopenic patients 
who had platelet count more than 50 × 109/L (OR 1.4; 
95% confidence interval (CI): 1.2-1.8; P = 00.1). 
DISCUSSION 
The prevalence of thrombocytopenia among 150 
patients (83 male and 67 female) admitted to ICU was 
detected in 53(35%) patients while 13 patients (8.6%) 
had severe thrombocytopenia (platelet count <50 × 
109/L). The current study results were consistent with 
those of previous studies reporting that 
thrombocytopenia can vary from 30% to 50% [1]. The 
wide range of prevalence might be due to different 
inclusion or exclusion criteria, condition or stage of 
patients, and quality of hospitalization. 
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Table 2: Variables between Groups 
 Thrombocytopenic (n = 53) Non-Thrombocytopenic (n = 97) P value 
Age (years) 61.3  ±  12.6 57.2  ±  11.7 0.4 
Gender (male) 26(49%) 57(58.7) 0.1 
BMI  (Kg/m2) 36.5  ±  7.6 33.2  ±  6.5 0.3 
Creatinine (mg/dl) 1.2  ±  0.8 1.3  ±  0.6 0.2 
Platelet on admission (×109/L) 243674 ± 7648 326154 ± 8031 0.6 
Systolic blood pressure (mmHg) 142.8 ± 11.4 138.7 ± 9.6 0.2 
Heart rate (bpm) 78.2 ± 5.3 83.6 ± 4.7 0.1 
Hospitalization duration (days) 16.1± 2.7 12.3±2.4 0.01 
Mortality (%) 24 (45.4%) 36 (37.5%) 0.001 
Data in are presented as No.(%) or Mean ± SD. 
BMI: Body Mass Index; bpm: beat per min 
 
Table 3: Severe Thrombocytopenia and Intensive Care Unit Admission Outcome 
 Severe Thrombocytopenia Platelet < 50 ×109/L 
(n=13) 




Discharge (%) 5 (39%) 24 (60%) 0.01 
Expire (%) 8 (61%) 16 (40%) 0.01 
Data in are presented as No. (%) 
In the current study, thrombocytopenia was detected in 
35% of patients, which was lower than that of the study 
by Thiery-Antier et al. reporting that 48.4% of patients 
had thrombocytopenia and 14.8% of them had platelet 
count <50 × 109/L [18]. According to the current study, 
thrombocytopenia was associated with increased 
hospitalization period and mortality rate in critically ill 
patients. The current study findings were similar to 
those of some studies suggesting that thrombocytopenia 
increases ICU length of stay and mortality in patients 
admitted to ICU [19]. 
Thrombocytopenia is a common disorder in ICU 
patients and prolonged thrombocytopenia is assumed 
to be associated with increased mortality. Due to the 
importance, many studies investigated the etiology of 
thrombocytopenia and its role on the prognosis in 
critically ill patients, but the exact reason is not clarified. 
It is believed that thrombocytopenia is multi-factorial 
and the fall in platelet count is caused by different 
mechanisms. Five major mechanisms such as 
hemodilution, increased platelet consumption, 
decreased platelet production, increased platelet 
sequestration, and platelet destruction due to immune 
mechanisms seem responsible for thrombocytopenia 
[20]. According to the authors` best knowledge there 
are limited data on sever thrombocytopenia in ICU 
patients [21, 22]. The current study also investigated 
the effect of sever thrombocytopenia (platelet count 
<50 × 109/L) on ICU mortality. The study observed 
sever thrombocytopenia in 8.3% of patients associated 
with increased mortality among patients with 
thrombocytopenia (OR 1.4; CI95% 1.2-1.8; P=00.1). 
Marco-Schulke et al., demonstrated a total of 11.7% 
developed sever thrombocytopenia in ICU patients, 
which was higher than our results [23]. 
The current study results showed that sever 
thrombocytopenia increased with mortality rate and low 
platelet scale was known as a poor prognostic factor. 
Although decrease in platelet count in critically ill 
patients is common and can be observed in different 
conditions, occurrence of sever thrombocytopenia 
reflects DIC and is correlated with coagulation disorders 
[24]. One of the most important causes of 
thrombocytopenia in ICU patients is bacterial infection, 
known as sepsis. During a septic shock, platelets can also 
be either activated by inflammatory mediators or 
directly by microorganism components [25]. Some 
studies show higher mortality in patients with acute 
kidney injury undergoing dialysis with 
thrombocytopenia fortifying inflammatory process 
[26]. The role of platelet in increasing mortality range is 
possibly due to its important role in inflammatory 
procedure and not in coagulation pathway. 
CONCLUSIONS 
Platelet alternation is one of the common hematologic 
abnormalities occurred by various conditions that might 
be considered as a prognosis monitor in ICU setting. 
Severe thrombocytopenia could be mentioned as a poor 
prognostic factor for increased mortality and prolonged 
hospitalization period in ICU patients.  
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